Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival

  1. Lianping Xing1,5,
  2. Ana M. Venegas2,5,
  3. Amy Chen2,
  4. Lisa Garrett-Beal2,
  5. Brendan F. Boyce1,
  6. Harold E. Varmus3,4, and
  7. Pamela L. Schwartzberg2,3,6
  1. 1Department of Pathology, University of Rochester, Rochester, New York 14627, USA; 2National Human Genome Research Institute and 3National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA

Abstract

Mutant src −/− mice have osteopetrosis resulting from defective osteoclasts, the cells that resorb bone. However, signaling pathways involving Src family members in osteoclasts remain unclear. We demonstrate that expression of a truncated Src molecule, Src251, lacking the kinase domain, induces osteopetrosis in wild-type and src +/− mice and worsens osteopetrosis in src −/− mice by a novel mechanism, increased osteoclast apoptosis. Induction of apoptosis by Src251 requires a functional SH2, but not an SH3, domain and is associated with reduced AKT kinase activity. Expression of Src251 dramatically reduces osteoclast survival in response to RANKL/TRANCE/OPGL, providing evidence that Src family kinases are required in vivo for survival signaling pathways downstream from TNF family receptors.

Keywords

Footnotes

  • 4 Present address: Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

  • 5 These authors contributed equally to this work.

  • 6 Corresponding author.

  • E-MAIL pams{at}nhgri.nih.gov; FAX (301) 402-2170.

  • Article and publication are at www.genesdev.org/cgi/doi10.1101/gad.840301.

    • Received August 1, 2000.
    • Accepted November 22, 2000.
| Table of Contents

Life Science Alliance